← Leaderboards
Tiarnan Keenan
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantAge Related Macular DegenerationRetinaProspectiveVisual AcuityGeographic AtrophyMaculaDiabetic RetinopathyCollectionRecruitRetinal DiseasesPhenotypeBiobankProtocols DocumentationAtrophicDoseBlindnessAdverse EventEtiologyImmuneGeographic LocationsFundusAreaAging
Grant awards (13)
Medical Retina Fellowship$694,813
ZIE · FY2025 · EY · contact PI
NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)$259,205
ZIA · FY2025 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$111,602
ZIA · FY2025 · EY · contact PI
Medical Retina Fellowship$663,079
ZIE · FY2024 · EY · contact PI
NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)$414,933
ZIA · FY2024 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$126,107
ZIA · FY2024 · EY · contact PI
NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)$215,553
ZIA · FY2023 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$204,006
ZIA · FY2023 · EY · contact PI
NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)$371,070
ZIA · FY2022 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$266,050
ZIA · FY2022 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$176,856
ZIA · FY2021 · EY · contact PI
NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)$167,548
ZIA · FY2021 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$222,291
ZIA · FY2020 · EY · contact PI